For: | Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588 [PMID: 39099827 DOI: 10.4239/wjd.v15.i7.1562] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i7/1562.htm |
Number | Citing Articles |
1 |
Dandan Liu, Hewei Qin, Guanghua Liu, Yang Gao, Yu Guo. Astragaloside IV inhibits atherosclerosis caused by ferritin autophagy in a lipid deposition environment by activating Nrf2. Journal of Functional Foods 2025; 126: 106695 doi: 10.1016/j.jff.2025.106695
|
2 |
Wenting Wang, Yiwen Li, Mengmeng Zhu, Qian Xu, Jing Cui, Yanfei Liu, Yue Liu. Danlian-Tongmai formula improves diabetic vascular calcification by regulating CCN3/NOTCH signal axis to inhibit inflammatory reaction. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1510030
|
3 |
Junhong Liu, Ziwei Li, ZongYao Zhang, Zhongyuan Shen. Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91264-w
|
4 |
Xin Zhang, Jing Zou, Jinghua Ning, Yanhong Zhao, Run Qu, Yuzhe Zhang. Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1500968
|